MARKET INTRODUCTION
The mRNA treatment involves mRNA sequences that play an essential role in protein synthesis, helping direct the disease's target. It allows replacing a defective gene through substitution and integration of the correct genetic code in the genome.
MARKET DYNAMICS
The mRNA treatment market growth is expected to grow faster due to increasing cancer, infectious diseases, and other chronic diseases. The rising investment in the biotechnology sectors is expected to enhance the market's growth during the forecast period. The market is expected to have growth opportunities due to the increasing adoption of molecular therapeutics for treating various chronic diseases.
MARKET SCOPE
The "mRNA Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of mRNA treatment market with detailed market segmentation by type, and application. The mRNA treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in mRNA treatment market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The mRNA treatment market is segmented on the basis of type, application. Based on type, the market is divided into stranded antisense oligonucleotides (ASOs), and double-stranded molecules. And based on application, the market is classified as personalized cancer vaccines, and infectious disease.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the mRNA treatment market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The mRNA treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting mRNA treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the mRNA treatment market in these regions.
MARKET PLAYERS
The report covers key developments in the mRNA treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from mRNA treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for mRNA treatment market in the global market. Below mentioned is the list of few companies engaged in the mRNA treatment.
The report also includes the profiles of key players in mRNA treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Argos Therapeutics, Inc.
- CureVac AG
- ethris GmbH
- Moderna, Inc.
- Sangamo Therapeutics, Inc.
- Translate Bio, Inc.
- Tiba Biotech
- BioNTech AG
- In-Cell-Art
- eTheRNA immunotherapies
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. PUBLISHERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 MRNA Treatment Market - By Type
1.3.2 MRNA Treatment Market - By Application
1.3.3 MRNA Treatment Market - By End User
1.3.4 MRNA Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MRNA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MRNA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MRNA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. MRNA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. MRNA TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. MRNA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. STRANDED ANTISENSE OLIGONUCLEOTIDES (ASOS)
7.3.1. Overview
7.3.2. Stranded Antisense Oligonucleotides (ASOs) Market Forecast and Analysis
7.4. DOUBLE-STRANDED MOLECULES
7.4.1. Overview
7.4.2. Double-stranded Molecules Market Forecast and Analysis
8. MRNA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PERSONALIZED CANCER VACCINES
8.3.1. Overview
8.3.2. Personalized Cancer Vaccines Market Forecast and Analysis
8.4. INFECTIOUS DISEASE
8.4.1. Overview
8.4.2. Infectious Disease Market Forecast and Analysis
9. MRNA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CANCER CENTERS
9.4.1. Overview
9.4.2. Cancer Centers Market Forecast and Analysis
9.5. RESEARCH AND DIAGNOSTIC LABORATORIES
9.5.1. Overview
9.5.2. Research and Diagnostic Laboratories Market Forecast and Analysis
10. MRNA TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America MRNA Treatment Market Overview
10.1.2 North America MRNA Treatment Market Forecasts and Analysis
10.1.3 North America MRNA Treatment Market Forecasts and Analysis - By Type
10.1.4 North America MRNA Treatment Market Forecasts and Analysis - By Application
10.1.5 North America MRNA Treatment Market Forecasts and Analysis - By End User
10.1.6 North America MRNA Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States MRNA Treatment Market
10.1.6.1.1 United States MRNA Treatment Market by Type
10.1.6.1.2 United States MRNA Treatment Market by Application
10.1.6.1.3 United States MRNA Treatment Market by End User
10.1.6.2 Canada MRNA Treatment Market
10.1.6.2.1 Canada MRNA Treatment Market by Type
10.1.6.2.2 Canada MRNA Treatment Market by Application
10.1.6.2.3 Canada MRNA Treatment Market by End User
10.1.6.3 Mexico MRNA Treatment Market
10.1.6.3.1 Mexico MRNA Treatment Market by Type
10.1.6.3.2 Mexico MRNA Treatment Market by Application
10.1.6.3.3 Mexico MRNA Treatment Market by End User
10.2. EUROPE
10.2.1 Europe MRNA Treatment Market Overview
10.2.2 Europe MRNA Treatment Market Forecasts and Analysis
10.2.3 Europe MRNA Treatment Market Forecasts and Analysis - By Type
10.2.4 Europe MRNA Treatment Market Forecasts and Analysis - By Application
10.2.5 Europe MRNA Treatment Market Forecasts and Analysis - By End User
10.2.6 Europe MRNA Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany MRNA Treatment Market
10.2.6.1.1 Germany MRNA Treatment Market by Type
10.2.6.1.2 Germany MRNA Treatment Market by Application
10.2.6.1.3 Germany MRNA Treatment Market by End User
10.2.6.2 France MRNA Treatment Market
10.2.6.2.1 France MRNA Treatment Market by Type
10.2.6.2.2 France MRNA Treatment Market by Application
10.2.6.2.3 France MRNA Treatment Market by End User
10.2.6.3 Italy MRNA Treatment Market
10.2.6.3.1 Italy MRNA Treatment Market by Type
10.2.6.3.2 Italy MRNA Treatment Market by Application
10.2.6.3.3 Italy MRNA Treatment Market by End User
10.2.6.4 Spain MRNA Treatment Market
10.2.6.4.1 Spain MRNA Treatment Market by Type
10.2.6.4.2 Spain MRNA Treatment Market by Application
10.2.6.4.3 Spain MRNA Treatment Market by End User
10.2.6.5 United Kingdom MRNA Treatment Market
10.2.6.5.1 United Kingdom MRNA Treatment Market by Type
10.2.6.5.2 United Kingdom MRNA Treatment Market by Application
10.2.6.5.3 United Kingdom MRNA Treatment Market by End User
10.2.6.6 Rest of Europe MRNA Treatment Market
10.2.6.6.1 Rest of Europe MRNA Treatment Market by Type
10.2.6.6.2 Rest of Europe MRNA Treatment Market by Application
10.2.6.6.3 Rest of Europe MRNA Treatment Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific MRNA Treatment Market Overview
10.3.2 Asia-Pacific MRNA Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific MRNA Treatment Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific MRNA Treatment Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific MRNA Treatment Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific MRNA Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia MRNA Treatment Market
10.3.6.1.1 Australia MRNA Treatment Market by Type
10.3.6.1.2 Australia MRNA Treatment Market by Application
10.3.6.1.3 Australia MRNA Treatment Market by End User
10.3.6.2 China MRNA Treatment Market
10.3.6.2.1 China MRNA Treatment Market by Type
10.3.6.2.2 China MRNA Treatment Market by Application
10.3.6.2.3 China MRNA Treatment Market by End User
10.3.6.3 India MRNA Treatment Market
10.3.6.3.1 India MRNA Treatment Market by Type
10.3.6.3.2 India MRNA Treatment Market by Application
10.3.6.3.3 India MRNA Treatment Market by End User
10.3.6.4 Japan MRNA Treatment Market
10.3.6.4.1 Japan MRNA Treatment Market by Type
10.3.6.4.2 Japan MRNA Treatment Market by Application
10.3.6.4.3 Japan MRNA Treatment Market by End User
10.3.6.5 South Korea MRNA Treatment Market
10.3.6.5.1 South Korea MRNA Treatment Market by Type
10.3.6.5.2 South Korea MRNA Treatment Market by Application
10.3.6.5.3 South Korea MRNA Treatment Market by End User
10.3.6.6 Rest of Asia-Pacific MRNA Treatment Market
10.3.6.6.1 Rest of Asia-Pacific MRNA Treatment Market by Type
10.3.6.6.2 Rest of Asia-Pacific MRNA Treatment Market by Application
10.3.6.6.3 Rest of Asia-Pacific MRNA Treatment Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa MRNA Treatment Market Overview
10.4.2 Middle East and Africa MRNA Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa MRNA Treatment Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa MRNA Treatment Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa MRNA Treatment Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa MRNA Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa MRNA Treatment Market
10.4.6.1.1 South Africa MRNA Treatment Market by Type
10.4.6.1.2 South Africa MRNA Treatment Market by Application
10.4.6.1.3 South Africa MRNA Treatment Market by End User
10.4.6.2 Saudi Arabia MRNA Treatment Market
10.4.6.2.1 Saudi Arabia MRNA Treatment Market by Type
10.4.6.2.2 Saudi Arabia MRNA Treatment Market by Application
10.4.6.2.3 Saudi Arabia MRNA Treatment Market by End User
10.4.6.3 U.A.E MRNA Treatment Market
10.4.6.3.1 U.A.E MRNA Treatment Market by Type
10.4.6.3.2 U.A.E MRNA Treatment Market by Application
10.4.6.3.3 U.A.E MRNA Treatment Market by End User
10.4.6.4 Rest of Middle East and Africa MRNA Treatment Market
10.4.6.4.1 Rest of Middle East and Africa MRNA Treatment Market by Type
10.4.6.4.2 Rest of Middle East and Africa MRNA Treatment Market by Application
10.4.6.4.3 Rest of Middle East and Africa MRNA Treatment Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America MRNA Treatment Market Overview
10.5.2 South and Central America MRNA Treatment Market Forecasts and Analysis
10.5.3 South and Central America MRNA Treatment Market Forecasts and Analysis - By Type
10.5.4 South and Central America MRNA Treatment Market Forecasts and Analysis - By Application
10.5.5 South and Central America MRNA Treatment Market Forecasts and Analysis - By End User
10.5.6 South and Central America MRNA Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil MRNA Treatment Market
10.5.6.1.1 Brazil MRNA Treatment Market by Type
10.5.6.1.2 Brazil MRNA Treatment Market by Application
10.5.6.1.3 Brazil MRNA Treatment Market by End User
10.5.6.2 Argentina MRNA Treatment Market
10.5.6.2.1 Argentina MRNA Treatment Market by Type
10.5.6.2.2 Argentina MRNA Treatment Market by Application
10.5.6.2.3 Argentina MRNA Treatment Market by End User
10.5.6.3 Rest of South and Central America MRNA Treatment Market
10.5.6.3.1 Rest of South and Central America MRNA Treatment Market by Type
10.5.6.3.2 Rest of South and Central America MRNA Treatment Market by Application
10.5.6.3.3 Rest of South and Central America MRNA Treatment Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MRNA TREATMENT MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. MRNA TREATMENT MARKET, KEY COMPANY PROFILES
13.1. ARGOS THERAPEUTICS, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CUREVAC AG
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ETHRIS GMBH
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. MODERNA, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. SANGAMO THERAPEUTICS, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. TRANSLATE BIO, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. TIBA BIOTECH
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BIONTECH AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. IN-CELL-ART
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ETHERNA IMMUNOTHERAPIES
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT PUBLISHERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Argos Therapeutics, Inc.
2. CureVac AG
3. ethris GmbH
4. Moderna, Inc.
5. Sangamo Therapeutics, Inc.
6. Translate Bio, Inc.
7. Tiba Biotech
8. BioNTech AG
9. In-Cell-Art
10. eTheRNA immunotherapies
Global Rare Hematology Market Growth Sta..
According to this study, over the next five years the Rare H..
+1-646-791 7070US (Toll Free)